VIRGINIA BEACH, Va., March 28, 2012 /PRNewswire/ -- Amerigroup Corporation (NYSE: AGP) announced its successful efforts at preventing premature births – as well its commitment to protecting access to affordable drug therapies for at-risk mothers – at the annual Norfolk/Virginia Beach March of Dimes kick-off breakfast for the March for Babies.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/amerigroup-preventing-preterm-births-with-affordable-drug-therapy-144667165.html
During the breakfast, the chief medical officer for Amerigroup, Dr. Mary McCluskey, shared an inspiring video about an expectant mother at risk for premature birth, and how the Company's commitment to providing access to an affordable drug therapy called 17-P helped her carry her baby to term and deliver a healthy, eight-pound baby boy.
According to the March of Dimes, premature births cost more than $26 billion a year in the United States. 17 alpha-hydroxyprogesterone caproate, commonly known as 17-P, is a vital drug therapy for pregnant women to reduce the number of preterm births. Recent studies have shown the use of 17-P reduces preterm delivery by as much as 33 percent.
"Amerigroup has a long history of achieving great results in lowering the incidence of preterm births among our members," McCluskey said. "In addition to reducing barriers to vital medications like 17-P, we are continuously looking for innovative ways to improve access and provide better quality of care for our expectant mothers to ensure more babies get the healthy start in life they deserve."
Amerigroup has enhanced as well as launched several programs focused on improving birth outcomes including a high-risk case management program that enables case managers to ensure at-risk members have careful monitoring, as well as any therapies including 17-P that help prevent preterm birth.
Last fall, the Company also launched the Warm Health pilot program in Texas, which provides both automated statewide Obstetrics (OB) assessments to screen for high-risk pregnancies and ongoing calls to mothers, both pre- and post-birth. The calls correspond with important times during a woman's pregnancy and are designed to inform them and encourage healthy behaviors.
Other ongoing Amerigroup programs focused on improving birth outcomes include:
- 17 alpha-hydroxyprogesterone caproate, or 17-P
- Provider education, orientation and office detailing
- Prior Preterm Pregnancy Program (P4)
- OB/NICU case management and weekly rounds
- You and Your Baby in NICU
- Outreach sponsorship of Text4Baby
- Taking Care of Baby and Me
About Real Stories
Amerigroup is a different kind of health insurance Company. We provide real solutions to members who need a little help by making the health care system work better for them. This series of documentaries shows how our case managers, care coordinators and contracted providers work together to help make a difference in our members' lives. Please visit www.amerigroup.com/real-stories to learn more.
About Amerigroup Corporation
Amerigroup, a Fortune 500 Company, coordinates services for individuals in publicly funded health care programs. Currently serving approximately 2 million members in 12 states nationwide, Amerigroup expects to expand operations in 2012 to Washington, its 13th state, as a result of a previously awarded state contract. Amerigroup is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. Amerigroup accepts all eligible people regardless of age, sex, race or disability. For more information, please visit www.amerigroup.com.
Investors: Julie Loftus Trudell
Senior Vice President, Investor Relations
News Media: Maureen C. McDonnell
Vice President, External Communications
SOURCE Amerigroup Corporation